Oakworth Capital’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-9
Closed 541
2021
Q4
$0 Hold
9
﹤0.01% 582
2021
Q3
$0 Hold
9
﹤0.01% 567
2021
Q2
$0 Sell
9
-1
-10% -$41 ﹤0.01% 579
2021
Q1
$0 Buy
10
+1
+11% +$47 ﹤0.01% 572
2020
Q4
$0 Hold
9
﹤0.01% 572
2020
Q3
$0 Hold
9
﹤0.01% 570
2020
Q2
$0 Hold
9
﹤0.01% 557
2020
Q1
$0 Hold
9
﹤0.01% 520
2019
Q4
$1K Hold
9
﹤0.01% 533
2019
Q3
$0 Hold
9
﹤0.01% 572
2019
Q2
$0 Hold
9
﹤0.01% 616
2019
Q1
$0 Hold
9
﹤0.01% 574
2018
Q4
$0 Sell
9
-109
-92% -$5.71K ﹤0.01% 571
2018
Q3
$8K Hold
118
﹤0.01% 473
2018
Q2
$7K Hold
118
﹤0.01% 500
2018
Q1
$6K Sell
118
-3
-2% -$142 ﹤0.01% 489
2017
Q4
$6K Sell
121
-187
-61% -$8.6K ﹤0.01% 499
2017
Q3
$13K Hold
308
﹤0.01% 445
2017
Q2
$12K Hold
308
﹤0.01% 447
2017
Q1
$12K Sell
308
-32
-9% -$1.25K ﹤0.01% 440
2016
Q4
$13K Buy
340
+32
+10% +$1.14K ﹤0.01% 424
2016
Q3
$10K Sell
308
-75
-20% -$2.63K ﹤0.01% 436
2016
Q2
$12K Buy
383
+274
+251% +$8.39K ﹤0.01% 399
2016
Q1
$3K Hold
109
﹤0.01% 464
2015
Q4
$4K Sell
109
-90
-45% -$2.8K ﹤0.01% 421
2015
Q3
$6K Hold
199
﹤0.01% 326
2015
Q2
$8K Hold
199
﹤0.01% 317
2015
Q1
$10K Hold
199
﹤0.01% 314
2014
Q4
$9K Buy
+199
New +$7.82K ﹤0.01% 323

Other funds holding AVNS

Oakworth Capital's AVNS Position: Q1 2022 in Review

Oakworth Capital sold out of Avanos Medical (AVNS) in Q1 2022, closing a stake of 9 shares.

Oakworth Capital first reported a position in AVNS in Q4 2014 and held it in 29 quarters. The position peaked at $13K in Q3 2017. 299 funds tracked by Wall St. Rank hold AVNS as of Q1 2022.

  • Oakworth Capital reported no remaining Avanos Medical position as of Q1 2022 after selling out during the quarter.
  • Oakworth Capital sold 9 Avanos Medical shares in Q1 2022.
  • Oakworth Capital first reported a position in Avanos Medical in Q4 2014 and held it in 29 quarters.
  • Oakworth Capital's Avanos Medical position peaked at $13K in Q3 2017.
  • 299 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2022.

Based on Oakworth Capital's 13F filing for Q1 2022, filed 11 Apr 2022.